|
2016 Updates from the Tuberculosis Scientific Committee and PHOENIx, a Trial of MDR-TB Prevention in Households
|
Anneke Hesseling and Amita Gupta
|
|
TB Trials in Adults and Opportunities for Children and Pregnant Women for MDR-TB, DS-TB
|
Kelly Dooley
|
|
Emerging Data on Key Second Line TB drugs in Children: Levofloxacin and Amikacin (Contact IMPAACT Operations Center)
|
Tony Garcia-Prats
|
|
Designing a MDR-TB Injectable Sparing Regimen in Children: Research Priorities, Design Considerations and Discussion
|
Anneke Hesseling and Simon Schaaf
|
|
Application of Pharmacometrics to TB PK Studies in Children and Pregnant Women – Case Based Experiences
|
Rada Savic
|
|
TB Biomarkers and Applications for TB Prevention Trials (Contact IMPAACT Operations Center)
|
Thomas Scriba
|
|
Utility of IGRAs in HIV-exposed and Infected Children in the IMPAACT P1041 TB Prevention Trial (Contact IMPAACT Operations Center)
|
Lisa Cranmer
|
